促性腺激素刺激降低人着床窗口期子宫自然杀伤细胞数量并损害其功能
前瞻性队列研究纳入51例受试者,比较自然周期与促性腺激素超排卵周期着床窗口期子宫内膜免疫细胞。超排卵组子宫内膜CD56+uNK细胞密度及uNK3亚群降低,B细胞比例升高,且uNK细胞促进EVT侵袭的能力受损。
要点
- 超排卵周期子宫内膜CD56+uNK细胞密度降低(P<0.05),uNK3亚群降低(P=0.025)。
- 超排卵周期子宫内膜B细胞比例升高(P<0.0001),外周血未见相应变化。
- 自然周期uNK细胞促进EVT侵袭(P=0.03),超排卵周期uNK细胞未能显著促进EVT侵袭。
核心结论
- 促性腺激素刺激改变着床窗口期uNK细胞分布并降低其促侵袭作用,可能解释新鲜IVF周期胎盘形成障碍风险增加。
研究设计与样本
- 2018年至2021年前瞻性队列研究,共51例受试者:自然周期20例于LH峰后8天取样,刺激IVF周期31例于取卵后7天取样。
主要发现
- 活检日血清雌二醇水平在超排卵组显著更高(P=0.0005)。
- 超排卵组子宫内膜CD56+uNK细胞密度降低(P<0.05),uNK3亚群(CD103+ NK细胞)降低(P=0.025)。
- 超排卵组子宫内膜B细胞比例升高(P<0.0001),外周血未见相应变化。
- 自然周期分泌期子宫内膜uNK细胞促进EVT侵袭(P=0.03),超排卵组uNK细胞未能显著促进EVT侵袭(以侵袭面积、侵袭深度和单位面积侵袭EVT数量衡量)。
- 分选uNK细胞RNA测序显示免疫细胞运输/运动和炎症相关信号通路改变。
局限性
- 研究患者数量少,但足以识别部分免疫细胞类型的显著总体差异。
- 增加样本量和更深入免疫表型分析可能检测到激素刺激下血液和子宫内膜免疫细胞组成的更多差异。
- 流式细胞术仅针对已知参与早期妊娠的免疫细胞群体,更无偏方法可能发现本研究未调查的新母体免疫细胞变化。
- RNA测序仅对uNK细胞进行,卵巢刺激可能影响其他免疫细胞亚群及子宫内膜其他细胞类型的基因表达和功能。
- IOC装置虽较现有体外方法有重大改进,但未包含早期妊娠所有母体细胞,可能影响观察到的功能效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How does an altered maternal hormonal environment, such as that seen during superovulation with gonadotropins in ART, impact human uterine immune cell distribution and function during the window of implantation? SUMMARY ANSWER: Hormonal stimulation with gonadotropins alters abundance of maternal immune cells including uterine natural killer (uNK) cells and reduces uNK cell ability to promote extravillous trophoblast (EVT) invasion. WHAT IS KNOWN ALREADY: An altered maternal hormonal environment, seen following ART, can lead to increased risk for adverse perinatal outcomes associated with disordered placentation. Maternal immune cells play an essential role in invasion of EVTs, a process required for proper establishment of the placenta, and adverse perinatal outcomes have been associated with altered immune cell populations. How ART impacts maternal immune cells and whether this can in turn affect implantation and placentation in humans remain unknown. STUDY DESIGN, SIZE, DURATION: A prospective cohort study was carried out between 2018 and 2021 on 51 subjects: 20 from natural cycles 8 days after LH surge; and 31 from stimulated IVF cycles 7 days after egg retrieval. PARTICIPANTS/MATERIALS, SETTING, METHODS: Endometrial biopsies and peripheral blood samples were collected during the window of implantation in subjects with regular menstrual cycles or undergoing superovulation. Serum estradiol and progesterone levels were measured by chemiluminescent competitive immunoassay. Immune cell populations in blood and endometrium were analyzed using flow cytometry. uNK cells were purified using fluorescence-activated cell sorting and were subjected to RNA sequencing (RNA-seq). Functional changes in uNK cells due to hormonal stimulation were evaluated using the implantation-on-a-chip (IOC) device, a novel bioengineered platform using human primary cells that mimics early processes that occur during pregnancy in a physiologically relevant manner. Unpaired t-tests, one-way ANOVA, and pairwise multiple comparison tests were used to statistically evaluate differences. MAIN RESULTS AND THE ROLE OF CHANCE: Baseline characteristics were comparable for both groups. As expected, serum estradiol levels on the day of biopsy were significantly higher in stimulated (superovulated) patients (P = 0.0005). In the setting of superovulation, we found an endometrium-specific reduction in the density of bulk CD56+ uNK cells (P < 0.05), as well as in the uNK3 subpopulation (P = 0.025) specifically (CD103+ NK cells). In stimulated samples, we also found that the proportion of endometrial B cells was increased (P < 0.0001). Our findings were specific to the endometrium and not seen in peripheral blood. On the IOC device, uNK cells from naturally cycling secretory endometrium promote EVT invasion (P = 0.03). However, uNK cells from hormonally stimulated endometrium were unable to significantly promote EVT invasion, as measured by area of invasion, depth of invasion, and number of invaded EVTs by area. Bulk RNA-seq of sorted uNK cells from stimulated and unstimulated endometrium revealed changes in signaling pathways associated with immune cell trafficking/movement and inflammation. LIMITATIONS, REASONS FOR CAUTION: Patient numbers utilized for the study were low but were enough to identify significant overall population differences in select immune cell types. With additional power and deeper immune phenotyping, we may detect additional differences in immune cell composition of blood and endometrium in the setting of hormonal stimulation. Flow cytometry was performed on targeted immune cell populations that have shown involvement in early pregnancy. A more unbiased approach might identify changes in novel maternal immune cells not investigated in this study. We performed RNA-seq only on uNK cells, which demonstrated differences in gene expression. Ovarian stimulation may also impact gene expression and function of other subsets of immune cells, as well as other cell types within the endometrium. Finally, the IOC device, while a major improvement over existing in vitro methods to study early pregnancy, does not include all possible maternal cells present during early pregnancy, which could impact functional effects seen. Immune cells other than uNK cells may impact invasion of EVTs in vitro and in vivo, though these remain to be tested. WIDER IMPLICATIONS OF THE FINDINGS: These findings demonstrate that hormonal stimulation affects the distribution of uNK cells during the implantation window and reduces the proinvasive effects of uNK cells during early pregnancy. Our results provide a potential mechanism by which fresh IVF cycles may increase risk of disorders of placentation, previously linked to adverse perinatal outcomes. STUDY FUNDING/COMPETING INTEREST(S): Research reported in this publication was supported by the University of Pennsylvania University Research Funding (to M.M.), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD068157 to M.M., S.S., and S.M.), National Center for Advancing Translational Sciences of the National Institutes of Health (TL1TR001880 to J.K.), the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania, the Children's Hospital of Philadelphia Research Institute (to S.M.G.), and the National Institute of Allergy and Infectious Diseases (K08AI151265 to S.M.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Kanter J, Gordon SM, Mani S, et al. Hormonal stimulation reduces numbers and impairs function of human uterine natural killer cells during implantation. Hum Reprod. 2023. PMID: 37075311. doi:10.1093/humrep/dead069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。